SE0201374D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number: SE0201374D0
Authority: SE; Sweden
Prior art keywords: pharmaceutical combination; compound; coagulant; pharmaceutically; acceptable salts
Prior art date: 2002-05-06

Application number

SE0201374A

Other languages

English (en)

Inventor

Ann-Charlotte Roth

Elisabeth Svernhage

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-06

Filing date

2002-05-06

Publication date

2002-05-06

2002-05-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-05-06 Priority to SE0201374A priority Critical patent/SE0201374D0/sv

2002-05-06 Publication of SE0201374D0 publication Critical patent/SE0201374D0/sv

2003-04-24 Priority to TW092109612A priority patent/TW200307549A/zh

2003-05-05 Priority to RU2004129729/15A priority patent/RU2004129729A/ru

2003-05-05 Priority to AU2003230517A priority patent/AU2003230517A1/en

2003-05-05 Priority to BR0309336-0A priority patent/BR0309336A/pt

2003-05-05 Priority to CNA038103273A priority patent/CN1652812A/zh

2003-05-05 Priority to EP03723588A priority patent/EP1503783A1/en

2003-05-05 Priority to CA002485086A priority patent/CA2485086A1/en

2003-05-05 Priority to MXPA04010717A priority patent/MXPA04010717A/es

2003-05-05 Priority to PL03372526A priority patent/PL372526A1/xx

2003-05-05 Priority to JP2004500903A priority patent/JP2005529140A/ja

2003-05-05 Priority to PCT/SE2003/000719 priority patent/WO2003092720A1/en

2003-05-05 Priority to KR10-2004-7017642A priority patent/KR20040104692A/ko

2003-05-05 Priority to US10/513,190 priority patent/US20050119259A1/en

2003-05-06 Priority to ARP030101592A priority patent/AR039883A1/es

2004-10-22 Priority to NO20044555A priority patent/NO20044555L/no

2004-10-25 Priority to ZA200408618A priority patent/ZA200408618B/en

2004-10-31 Priority to IL16493904A priority patent/IL164939A0/xx

2004-11-18 Priority to IS7536A priority patent/IS7536A/is

Links

150000001875 compounds Chemical class 0.000 abstract 2
229940126062 Compound A Drugs 0.000 abstract 1
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
206010003119 arrhythmia Diseases 0.000 abstract 1
230000006793 arrhythmia Effects 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
239000013066 combination product Substances 0.000 abstract 1
229940127555 combination product Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

SE0201374A 2002-05-06 2002-05-06 Pharmaceutical combination SE0201374D0 (sv)

Priority Applications (19)

Application Number	Priority Date	Filing Date	Title
SE0201374A SE0201374D0 (sv)	2002-05-06	2002-05-06	Pharmaceutical combination
TW092109612A TW200307549A (en)	2002-05-06	2003-04-24	Pharmaceutical combination
US10/513,190 US20050119259A1 (en)	2002-05-06	2003-05-05	Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
MXPA04010717A MXPA04010717A (es)	2002-05-06	2003-05-05	Un producto de combinacion que comprende un anticoagulante y oxabispidinas antiarritmicas.
PCT/SE2003/000719 WO2003092720A1 (en)	2002-05-06	2003-05-05	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
BR0309336-0A BR0309336A (pt)	2002-05-06	2003-05-05	Produto de combinação, conjunto de partes, métodos para fabricar um conjunto de partes, e para tratar arritmia, e, usos de um produto de combinação, de anti-coagulante ou um derivado farmaceuticamente aceitável deste, e de um melagratan ou um derivado farmaceuticamente aceitável deste
CNA038103273A CN1652812A (zh)	2002-05-06	2003-05-05	含抗凝血剂和抗心率失常的oxabispidine的组合产品
EP03723588A EP1503783A1 (en)	2002-05-06	2003-05-05	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
CA002485086A CA2485086A1 (en)	2002-05-06	2003-05-05	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
RU2004129729/15A RU2004129729A (ru)	2002-05-06	2003-05-05	Комбинированный продукт, содержащий антикоагулянт и антиаритмические оксабиспидины
PL03372526A PL372526A1 (en)	2002-05-06	2003-05-05	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
JP2004500903A JP2005529140A (ja)	2002-05-06	2003-05-05	抗凝固剤及び抗不整脈オキサビスピジンを含む複合生成物
AU2003230517A AU2003230517A1 (en)	2002-05-06	2003-05-05	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
KR10-2004-7017642A KR20040104692A (ko)	2002-05-06	2003-05-05	항응고제와 항부정맥성 옥사비스피딘을 포함하는 배합 산물
ARP030101592A AR039883A1 (es)	2002-05-06	2003-05-06	Combinacion farmaceutica
NO20044555A NO20044555L (no)	2002-05-06	2004-10-22	Kombinasjonsprodukt omfattende en antikoagulant og anti-arrytmiske oksabispidener
ZA200408618A ZA200408618B (en)	2002-05-06	2004-10-25	A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
IL16493904A IL164939A0 (en)	2002-05-06	2004-10-31	A combination product comprising an anti-coagulantand anti-arrhythmic ocabispidines
IS7536A IS7536A (is)	2002-05-06	2004-11-18	Samsett afurð sem inniheldur blóðstorkuhefti og sláttarglapastillandi oxabispíden.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0201374A SE0201374D0 (sv)	2002-05-06	2002-05-06	Pharmaceutical combination

Publications (1)

Publication Number	Publication Date
SE0201374D0 true SE0201374D0 (sv)	2002-05-06

Family

ID=20287789

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0201374A SE0201374D0 (sv)	2002-05-06	2002-05-06	Pharmaceutical combination

Country Status (19)

Country	Link
US (1)	US20050119259A1 (sv)
EP (1)	EP1503783A1 (sv)
JP (1)	JP2005529140A (sv)
KR (1)	KR20040104692A (sv)
CN (1)	CN1652812A (sv)
AR (1)	AR039883A1 (sv)
AU (1)	AU2003230517A1 (sv)
BR (1)	BR0309336A (sv)
CA (1)	CA2485086A1 (sv)
IL (1)	IL164939A0 (sv)
IS (1)	IS7536A (sv)
MX (1)	MXPA04010717A (sv)
NO (1)	NO20044555L (sv)
PL (1)	PL372526A1 (sv)
RU (1)	RU2004129729A (sv)
SE (1)	SE0201374D0 (sv)
TW (1)	TW200307549A (sv)
WO (1)	WO2003092720A1 (sv)
ZA (1)	ZA200408618B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20042068A1 (it) *	2004-10-29	2005-01-29	Opocrin Spa	Nuovo uso di eparine a bassissimo peso molecolare
WO2006137772A1 (en) *	2005-06-20	2006-12-28	Astrazeneca Ab	New physical form of n,n´- disubstituted oxabispidines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU178398B (en) *	1979-06-12	1982-04-28	Gyogyszerkutato Intezet	Process for producing new agmatine derivatives of activity against haemagglutination
SE9903759D0 (sv) *	1999-10-18	1999-10-18	Astra Ab	Pharmaceutically active compounds
US6462021B1 (en) *	2000-11-06	2002-10-08	Astrazeneca Ab	Use of low molecular weight thrombin inhibitor

2002
- 2002-05-06 SE SE0201374A patent/SE0201374D0/sv unknown
2003
- 2003-04-24 TW TW092109612A patent/TW200307549A/zh unknown
- 2003-05-05 WO PCT/SE2003/000719 patent/WO2003092720A1/en active Application Filing
- 2003-05-05 PL PL03372526A patent/PL372526A1/xx not_active Application Discontinuation
- 2003-05-05 MX MXPA04010717A patent/MXPA04010717A/es unknown
- 2003-05-05 AU AU2003230517A patent/AU2003230517A1/en not_active Abandoned
- 2003-05-05 RU RU2004129729/15A patent/RU2004129729A/ru not_active Application Discontinuation
- 2003-05-05 CN CNA038103273A patent/CN1652812A/zh active Pending
- 2003-05-05 JP JP2004500903A patent/JP2005529140A/ja active Pending
- 2003-05-05 BR BR0309336-0A patent/BR0309336A/pt not_active IP Right Cessation
- 2003-05-05 KR KR10-2004-7017642A patent/KR20040104692A/ko not_active Application Discontinuation
- 2003-05-05 EP EP03723588A patent/EP1503783A1/en not_active Withdrawn
- 2003-05-05 CA CA002485086A patent/CA2485086A1/en not_active Abandoned
- 2003-05-05 US US10/513,190 patent/US20050119259A1/en not_active Abandoned
- 2003-05-06 AR ARP030101592A patent/AR039883A1/es not_active Application Discontinuation
2004
- 2004-10-22 NO NO20044555A patent/NO20044555L/no unknown
- 2004-10-25 ZA ZA200408618A patent/ZA200408618B/en unknown
- 2004-10-31 IL IL16493904A patent/IL164939A0/xx unknown
- 2004-11-18 IS IS7536A patent/IS7536A/is unknown

Also Published As

Publication number	Publication date
CA2485086A1 (en)	2003-11-13
US20050119259A1 (en)	2005-06-02
MXPA04010717A (es)	2005-03-07
IL164939A0 (en)	2005-12-18
WO2003092720A1 (en)	2003-11-13
ZA200408618B (en)	2006-06-28
JP2005529140A (ja)	2005-09-29
NO20044555L (no)	2004-11-16
TW200307549A (en)	2003-12-16
RU2004129729A (ru)	2005-07-10
PL372526A1 (en)	2005-07-25
AU2003230517A1 (en)	2003-11-17
CN1652812A (zh)	2005-08-10
AR039883A1 (es)	2005-03-09
BR0309336A (pt)	2005-03-08
EP1503783A1 (en)	2005-02-09
IS7536A (is)	2004-11-18
WO2003092720A8 (en)	2005-03-10
KR20040104692A (ko)	2004-12-10

Similar Documents

Publication	Publication Date	Title
DE50311898D1 (de)	2009-10-22	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BG106825A (en)	2003-02-28	Substituted oxazolidinones and their use in the field of blood coagulation
ATE408601T1 (de)	2008-10-15	Fredericamycin-derivate
BR0215240A (pt)	2004-10-26	Derivados de calcona e seu uso no tratamento de doenças
BRPI0410979A (pt)	2006-07-04	composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
IL165264A (en)	2011-07-31	Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
EA200501095A1 (ru)	2006-04-28	Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
EA200500853A1 (ru)	2006-08-25	2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
ATE346039T1 (de)	2006-12-15	Sulfonamido-substituierte verbrückte bicycloalkylderivative
SE0101387D0 (sv)	2001-04-20	Novel compounds
EE05419B1 (et)	2011-06-15	Asendatud oksasolidinoonid kombineeritud raviks
GB0005251D0 (en)	2000-04-26	Therapeutic compounds
SE9604786D0 (sv)	1996-12-20	New compounds
DE502004005033D1 (de)	2007-10-31	Substituierte 2-aminotetraline zur behandlung von depressionen
EA200500399A1 (ru)	2005-12-29	Ненуклеозидные ингибиторы обратной транскриптазы
ZA200508889B (en)	2007-02-28	Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxomorpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor Xa in the treatment of thrombo-embolic diseases
CY1109013T1 (el)	2014-07-02	Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DK0669912T3 (da)	2002-03-04	N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
CY1107616T1 (el)	2013-03-13	Καινοτομος χρηση της 2-[5-(4-φθοροφαινυλο)-3-πυριδυλομεθυλαμινομεθυλο]-χρωμανης και των φυσιολογικα αποδεκτων αλατων της
ATE417608T1 (de)	2009-01-15	Arzneizusammensetzungen enthaltend modafinilverbindungen
CY1105317T1 (el)	2010-03-03	Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el)	2009-11-04	Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
SE0201662D0 (sv)	2002-05-31	Pharmaceutical combination
WO2004016741A3 (en)	2004-04-08	Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use